Active	Status	Sponsor type	Region	Phase	Filter
7 Active 1 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Minniti, Giuseppe
MIRAGE, NCT06275919: Regorafenib for Recurrent Grade 2 and 3 Meningioma ( Trial)	Not yet recruiting	2	104	Europe	Regorafenib 40 MG Oral Tablet, Local Standard of Care	Istituto Oncologico Veneto IRCCS, Bayer	Meningioma, Malignant	12/26	03/27
SURE-AVR, NCT02679404: Sorin Universal REgistry on Aortic Valve Replacement	Terminated	N/A	2758	Europe, Canada, US, RoW		Corcym S.r.l	Aortic Valve Disease, Aortic Stenosis	03/21	03/21
MANTRA, NCT05002543: CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting	Recruiting	N/A	2150	Europe, Canada, US, RoW		Corcym S.r.l	Cardiac Valve Disease	08/25	12/35
Nevinny-Stickel, Meinhard
No trials found